|
AU509682B2
(en)
|
1975-10-28 |
1980-05-22 |
Eli Lilly And Company |
2-Aroyl-3-Phenylbenzothiophene Derivatives
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
EP0146243A1
(en)
|
1983-10-31 |
1985-06-26 |
Merck Frosst Canada Inc. |
Lipoxygenase inhibitors
|
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
|
EP0752421B1
(en)
|
1995-07-07 |
2005-10-12 |
AstraZeneca AB |
Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
TW397821B
(en)
|
1996-04-19 |
2000-07-11 |
American Home Produits Corp |
3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
|
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
|
JP2001519349A
(ja)
|
1997-10-03 |
2001-10-23 |
イーライ・リリー・アンド・カンパニー |
ベンゾチオフェン
|
|
US6326392B1
(en)
|
1997-11-06 |
2001-12-04 |
American Home Products Corporation |
Anti-estrogen plus progestin containing oral contraceptives
|
|
ID24568A
(id)
|
1997-11-06 |
2000-07-27 |
American Home Prod |
Kontrasepsi oral yang mengandung anti-estrogen plus progestin
|
|
US6060488A
(en)
*
|
1998-09-22 |
2000-05-09 |
Eli Lilly And Company |
Benzothiophenes for treating estrogen deficiency
|
|
CO5271696A1
(es)
|
2000-01-12 |
2003-04-30 |
Pfizer Prod Inc |
Procedimiento para reducir la morbilidad y el riesgo de mortalidad
|
|
US7091240B2
(en)
|
2000-03-10 |
2006-08-15 |
Oxigene, Inc. |
Tubulin binding ligands and corresponding prodrug constructs
|
|
WO2002003989A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
EP1990051A1
(en)
|
2000-07-06 |
2008-11-12 |
Wyeth |
Combinations of SSRI and estrogenic agents
|
|
MXPA02012890A
(es)
|
2000-07-06 |
2003-10-24 |
Wyeth Corp |
Uso de compuestos de indol sustituidos para incrementar la actividad de oxido nitrico sintasa.
|
|
JP2004502731A
(ja)
|
2000-07-06 |
2004-01-29 |
ワイス |
スタチン、エストロゲン剤および所望によるエストロゲンの組み合わせ
|
|
AR030064A1
(es)
|
2000-07-06 |
2003-08-13 |
Wyeth Corp |
Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
|
|
MXPA02012897A
(es)
|
2000-07-06 |
2003-10-24 |
Wyeth Corp |
Combinaciones de bisfosfonatos, agentes estrigenicos y opcionalmente estrogenos.
|
|
US20020016318A1
(en)
|
2000-07-06 |
2002-02-07 |
American Home Products Corporation |
Methods of treating breast disorders
|
|
US6358991B2
(en)
|
2000-07-06 |
2002-03-19 |
American Home Products Corporation |
Methods of treating neuropeptide Y-related conditions
|
|
AU2001271782A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Use of substituted insole compounds for treating excessive intraocular pressure
|
|
AU2001271784A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Therapy for prosthesis-related bone degeneration
|
|
JP2004507465A
(ja)
|
2000-08-11 |
2004-03-11 |
ワイス |
エストロゲン受容体陽性癌腫の治療方法
|
|
JP2007502307A
(ja)
|
2003-08-15 |
2007-02-08 |
アストラゼネカ アクチボラグ |
グルタミン酸ラセマーゼ（ｍｕｒｉ）の阻害剤としての縮合複素環
|
|
FR2862646B1
(fr)
|
2003-11-20 |
2006-02-24 |
Merck Sante Sas |
Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
|
|
CA2595477A1
(en)
|
2005-01-21 |
2006-07-27 |
Janssen Pharmaceutica N.V. |
Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
|
|
US8278290B2
(en)
|
2005-02-14 |
2012-10-02 |
Biononics Limited |
Tubulin polymerisation inhibitors
|
|
AU2007211840B2
(en)
|
2006-02-03 |
2012-03-01 |
Bionomics Limited |
Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
|
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
|
EP1947085A1
(en)
|
2007-01-19 |
2008-07-23 |
Laboratorios del Dr. Esteve S.A. |
Substituted indole sulfonamide compounds, their preparation and use as medicaments
|
|
EP2183237A1
(en)
|
2007-07-25 |
2010-05-12 |
F. Hoffmann-Roche AG |
Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
|
|
WO2010093578A1
(en)
|
2009-02-10 |
2010-08-19 |
Glaxo Group Limited |
Indolinyl-, benzofuranyl-, and benzothienyl- amides as modulators of chemokine receptors
|
|
WO2010127452A1
(en)
|
2009-05-04 |
2010-11-11 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
5-oxo-ete receptor antagonist compounds
|
|
HUE033581T2
(hu)
|
2010-06-10 |
2017-12-28 |
Seragon Pharmaceuticals Inc |
Ösztrogén receptor modulátorok és alkalmazásaik
|
|
GB2483736B
(en)
|
2010-09-16 |
2012-08-29 |
Aragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
CA2819299A1
(en)
|
2010-12-24 |
2012-06-28 |
Merck Sharp & Dohme B.V. |
N-substituted azetidine derivatives
|
|
DE102011087987A1
(de)
|
2011-12-08 |
2013-06-13 |
Bayer Intellectual Property Gmbh |
6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
JP6112625B2
(ja)
|
2011-12-14 |
2017-04-12 |
セラゴン ファーマシューティカルズ，インク． |
フッ素化したエストロゲン受容体モジュレーターおよびその使用
|
|
PE20150099A1
(es)
|
2011-12-16 |
2015-01-30 |
Olema Pharmaceuticals Inc |
Compuestos novedosos de benzopirano, composiciones y usos de los mismos
|
|
JP2015505562A
(ja)
|
2012-01-31 |
2015-02-23 |
ノバルティス アーゲー |
Ｒｔｋ阻害剤と抗エストロゲン剤との組合せ、およびがん治療のためのその使用
|
|
SG11201405918XA
(en)
|
2012-03-20 |
2014-10-30 |
Seragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
WO2014066692A1
(en)
|
2012-10-24 |
2014-05-01 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating estrogen-related medical disorders
|
|
EP2912033A4
(en)
|
2012-10-24 |
2016-09-14 |
Univ Illinois |
COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES
|
|
BR112015018882B1
(pt)
*
|
2013-02-19 |
2021-09-14 |
Novartis Ag |
Derivados de benzotiofeno e composições dos mesmos como degradadores de receptor de estrogênio seletivo
|
|
JP2016517420A
(ja)
|
2013-03-14 |
2016-06-16 |
セラゴン ファーマシューティカルズ， インク． |
多環式エストロゲン受容体モジュレーター及びその使用
|
|
TWI653235B
(zh)
|
2013-05-28 |
2019-03-11 |
阿斯特捷利康公司 |
作為抗癌劑之吲哚衍生物
|
|
BR112015030595A2
(pt)
|
2013-06-19 |
2017-07-25 |
Seragon Pharmaceuticals Inc |
moduladores de receptor de estrogênio de azetidina e usos dos mesmos
|
|
WO2014203132A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Substituted benzopyran compounds, compositions and uses thereof
|
|
EA031077B1
(ru)
|
2013-06-19 |
2018-11-30 |
Серагон Фармасьютикалз, Инк. |
Модулятор рецептора эстрогена и его применения
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
GB201311888D0
(en)
*
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
WO2015028409A1
(de)
|
2013-08-27 |
2015-03-05 |
Bayer Pharma Aktiengesellschaft |
6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
CA2941161A1
(en)
|
2014-03-13 |
2015-09-17 |
F.Hoffmann-La Roche Ag |
Methods and compositions for modulating estrogen receptor mutants
|
|
JP2017507964A
(ja)
|
2014-03-13 |
2017-03-23 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
エストロゲン受容体モジュレーターを用いた治療的組合せ
|
|
FI3834824T3
(fi)
|
2014-03-28 |
2025-12-05 |
Univ Duke |
Estrogeenireseptoripositiivisen rintasyövän hoito selektiivisellä estrogeenireseptorin modulaattorilla
|
|
CN107406424B
(zh)
|
2014-12-18 |
2020-08-25 |
豪夫迈·罗氏有限公司 |
雌激素受体调节剂及其用途
|
|
KR102785474B1
(ko)
|
2014-12-18 |
2025-03-26 |
에프. 호프만-라 로슈 아게 |
테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체 조절제 및 이의 용도
|
|
EP3233818A1
(en)
|
2014-12-18 |
2017-10-25 |
F. Hoffmann-La Roche AG |
Derivatives of 2,3-diphenylchromene useful for the treatment of cancer
|
|
EP3303326B1
(en)
|
2015-05-26 |
2020-12-16 |
H. Hoffnabb-La Roche Ag |
Heterocyclic estrogen receptor modulators and uses thereof
|
|
KR102710603B1
(ko)
|
2015-10-01 |
2024-09-27 |
올레마 파마슈티컬스 인코포레이티드 |
테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
|
|
WO2017056115A1
(en)
|
2015-10-03 |
2017-04-06 |
Sun Pharma Advanced Research Company Limited |
Novel n-aryl containing fused heterocyclic compounds
|
|
US9975856B2
(en)
|
2015-10-07 |
2018-05-22 |
Genentech, Inc. |
Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
|
|
MX385940B
(es)
|
2015-10-27 |
2025-03-18 |
Sun Pharma Advanced Res Co Ltd |
Nuevos antiestrógenos heterocíclicos.
|
|
SMT202300018T1
(it)
|
2015-12-09 |
2023-03-17 |
Univ Illinois |
Downregolatori del recettore degli estrogeni a base di benzotiofene
|
|
LT3416962T
(lt)
|
2016-02-15 |
2021-07-12 |
Sanofi |
6,7-dihidro-5h-benzo[7]anuleno dariniai kaip estrogenų recepptoriaus moduliatoriai
|